SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-13-277164
Filing Date
2013-06-28
Accepted
2013-06-28 16:01:35
Documents
7
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d558258d10ka.htm 10-K/A 915277
2 EX-23.1 d558258dex231.htm EX-23.1 2030
3 EX-23.2 d558258dex232.htm EX-23.2 2007
4 EX-31.1 d558258dex311.htm EX-31.1 9093
5 EX-31.2 d558258dex312.htm EX-31.2 9162
6 EX-32.1 d558258dex321.htm EX-32.1 3418
7 EX-32.2 d558258dex322.htm EX-32.2 3502
  Complete submission text file 0001193125-13-277164.txt   945632
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33038 | Film No.: 13940917
SIC: 8093 Services-Specialty Outpatient Facilities, NEC